Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EGFR | P00533 | 9/20 | 0.82 |
| ▸ | LCK | P06239 | 2/20 | 0.80 |
| ▸ | RAF1 | P04049 | 1/20 | 0.75 |
| ▸ | BRAF | P15056 | 1/20 | 0.75 |
| ▸ | FBP1 | P09467 | 1/20 | 0.68 |
| ▸ | KDR | P35968 | 9/20 | 0.67 |
| ▸ | RET | P07949 | 7/20 | 0.67 |
| ▸ | KIF5B | P33176 | 4/20 | 0.67 |
| ▸ | FGFR1 | P11362 | 1/20 | 0.67 |
| ▸ | FLT1 | P17948 | 1/20 | 0.67 |
| ▸ | CDK2 | P24941 | 1/20 | 0.67 |
| ▸ | PIK3R1 | P27986 | 1/20 | 0.67 |
| ▸ | EPHB2 | P29323 | 1/20 | 0.67 |
| ▸ | TTBK1 | Q5TCY1 | 1/20 | 0.67 |
| ▸ | NOD1 | Q9Y239 | 2/20 | 0.66 |
| ▸ | RIPK2 | O43353 | 1/20 | 0.65 |
| ▸ | AURKA | O14965 | 1/20 | 0.62 |
| ▸ | AURKB | Q96GD4 | 1/20 | 0.62 |
| ▸ | SRC | P12931 | 1/20 | 0.62 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5482884 | 0.90 | EGFR (1.00) | EGFRLCKRAF1FBP1KDR | |
| Hydrochloric Acid SCHEMBL5475745 | 0.89 | EGFR (1.00) | EGFRLCKRAF1FBP1KDR | |
| SCHEMBL13604745 | 0.88 | EGFR (0.82) | EGFRLCKRAF1BRAFKDR | |
| SCHEMBL2100551 | 0.87 | EGFR (0.82) | EGFRLCKRAF1BRAFFBP1 | |
| SCHEMBL6674055 | 0.87 | KDR (0.82) | EGFRLCKRAF1BRAFFBP1 | |
| SCHEMBL22367405 | 0.86 | EGFR (0.82) | EGFRFBP1KDRRETKIF5B | |
| SCHEMBL15052584 | 0.86 | BRAF (1.00) | RAF1BRAF | |
| SCHEMBL14964757 | 0.84 | EGFR (0.81) | EGFRLCKRAF1BRAFKDR | |
| SCHEMBL5239599 | 0.84 | EGFR (0.80) | EGFRLCKRAF1BRAFKDR | |
| SCHEMBL13285584 | 0.83 | EGFR (0.83) | EGFRLCKRAF1BRAFFBP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120046461-A1 | STEROIDAL ANTI-HORMONE HYBRIDS | NORTHEASTERN UNIVERSITY (US) | 2012-02-23 | — | — | US | disclosed |
| US-20120046461-A1 | STEROIDAL ANTI-HORMONE HYBRIDS | NORTHEASTERN UNIVERSITY (US) | 2012-02-23 | — | — | US | disclosed |
| WO-2010085747-A1 | STEROIDAL ANTI-HORMONE HYBRIDS | NORTHEASTERN UNIVERSITY (US) | 2010-07-29 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120046461-A1 | STEROIDAL ANTI-HORMONE HYBRIDS | ESRRA, ESRRB, NR5A1 | EGFR 768/4885LCK 4032/4885RAF1 4129/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.